Breast cancer might be one of the most common cancers for women, but with screening tools like the Cloud 4 Cancer app, the death rates have been steadily decreasing over the years. Impressively created by a 17 year old high school junior, the Cloud 4 Cancer app is a minimally invasive tool that will help doctors diagnose breast cancer earlier. Although it has been found that the less invasive a test is, the less accurate it is as well, this tool goes against that proof.
Essentially, Brittany Wenger’s Cloud 4 Cancer app works in tangent with Fine Needle Aspirates (FNA) findings to figure out if a mass is malignant or benign. Using an artificial neuron network, which learns just like humans, it improves with every test it takes. Currently, it boasts 99.1% accuracy.
Why This Trend Is Growing
- Minimally Invasive Medical Tools
- The success of the Cloud 4 Cancer app highlights opportunities for the development of other minimally invasive medical tools.
- AI-powered Screening Apps
- The use of artificial neuron networks in the Cloud 4 Cancer app showcases the potential for AI-powered screening apps in the medical industry.
- Innovative Cancer Diagnostic Tools
- The Cloud 4 Cancer app is an example of the importance of creating innovative cancer diagnostic tools to improve patient outcomes and save lives.
Industries Being Reshaped
- Healthcare Technology
- The growing demand for healthcare technology presents an opportunity for companies to develop and market similar cancer screening apps.
- Artificial Intelligence
- The use of artificial neuron networks in the Cloud 4 Cancer app highlights the potential for AI to revolutionize the healthcare industry.
- Cancer Research
- The accuracy of the Cloud 4 Cancer app demonstrates the importance of investing in cancer research to develop better diagnostic tools and treatments.
